Section or Unit Name
Laboratory of Animal Medicine Section
Exclude from directory
Off
Section/Unit: Location
This Researcher/Clinician’s Person Page
Parent Lab/Program
Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed)
The INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project encourages grant applications aimed at developing, characterizing, or improving animal models and related biological materials for Down syndrome (DS) related research and improving access to information about or from the use of animal models for DS research. The animal models and related biological materials developed must have utility in targeted or basic science studies in areas highly relevant to DS.
Resources for Researchers
NIAID offers many resources to support your research, including reagents, model organisms, and tissue samples, to name just a few. Use the filters under Filter Search Results to narrow your search, or simply enter specific search terms in the search field.
108 Results
Al Jalila Foundation Partners with America’s NIH and Major UAE Universities to Establish a Collaborative Scientific Research Initiative
Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.aljalilafoundation.ae/al-jalila-foundation-partners-with-americas-nih-and-major-uae-universities-to-establish-a-collaborative-scientific-research-initiative/
Research Institution
Al Jalila Foundation
Short Title
Al Jalila Foundation Partners with America’s NIH and Major UAE Universities
Content Coordinator
Content Manager
Dolutegravir-Based Antiretroviral Therapies for HIV-1 Effective in Pregnancy
Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.luriechildrens.org/en/news-stories/dolutegravir-based-antiretroviral-therapies-for-hiv-1-effective-in-pregnancy/
Research Institution
Ann & Robert H. Lurie Children’s Hospital of Chicago
Short Title
Dolutegravir-Based Antiretroviral Therapies for HIV-1 Effective in Pregnancy
Content Coordinator
Content Manager
Vanderbilt, NIH and the Institut National de Recherche Biomédicale Team Up to Tackle Monkeypox
Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://news.vanderbilt.edu/2022/09/15/vanderbilt-nih-and-the-institut-national-de-recherche-biomedicale-team-up-to-tackle-monkeypox%E2%80%AF/
Research Institution
Vanderbilt University
Short Title
Vanderbilt, NIH and the Institut National de Recherche Biomédicale Team Up to Tackle Monkeypox
Content Coordinator
Content Manager
License to Kill—Latency HIV-CRISPR Pinpoints How to Blow Latent HIV’s Cover
Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.fredhutch.org/en/news/spotlight/2022/09/ccg-hsieh-bioRxiv.html
Research Institution
Fred Hutchinson Cancer Center
Short Title
License to Kill—Latency HIV-CRISPR Pinpoints How to Blow Latent HIV’s Cover
Content Coordinator
Content Manager
NIH Funds UAMS Study Testing Rapid Genomic Surveillance for Antibiotic Resistant Infections
Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://medicine.uams.edu/dbmi/news/nih-funds-uams-study-testing-rapid-genomic-surveillance-for-antibiotic-resistant-infections/
Research Institution
University of Arkansas for Medical Sciences
Short Title
NIH Funds UAMS Study Testing Rapid Genomic Surveillance for Antibiotic Resistant Infections
Content Coordinator
Content Manager
Universal Flu Vaccine Protects Against Variants of Both Influenza A and B Viruses, Biomedical Sciences Researchers Find
Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://news.gsu.edu/2022/08/29/universal-flu-vaccine-protects-against-variants-of-both-influenza-a-and-b-viruses-biomedical-sciences-researchers-find/
Research Institution
Georgia State University
Short Title
Universal Flu Vaccine Protects Against Variants of Both Influenza A and B Viruses
Content Coordinator
Content Manager
IAVI Announces First Vaccinations at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate
Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.iavi.org/news-resources/press-releases/2022/iavi-announces-first-vaccinations-at-liberia-site-in-phase-i-clinical-trial-of-lassa-fever-vaccine-candidate
Research Institution
IAVI
Short Title
IAVI Announces First Vaccinations at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate
Content Coordinator
Content Manager